
Together with our estimated partner AFMS, EEMEA Marketing and Scientific Team organized in Riyadh (KSA) the 2024 edition of the Scientific Seminars from November 4 to 6.
Werfen through its team in EEMEA and Italy, continued its commitment to advancing the fight against cancer-related blood clots by being a bronze sponsor at the recently concluded 12th International Conference on Thrombosis and Hemostasis Issues in Cancer (ICTHIC 2024).
In today's healthcare environment, interdisciplinary dialogue and collaboration are essential for driving progress in patient care, especially in Acute Care Settings.
The landscape of laboratory medicine is in continuous evolution. Demands of the laboratory continue to increase while resources and laboratory technicians are becoming scarce resources.
One of the most fulfilling lessons in life is learning to share. From an early age, sharing a toy, a meal, a story, or time with others strengthens confidence and builds connection.
In recognition of World Hemophilia Day on April 17, we launched an awareness campaign centered around two key initiatives:
The installation of the first HemoCell in Greece marked a significant milestone for both Werfen and Antisel.
We are very proud to announce that our new GEM Premier 7000 with iQM3—the first-ever, rapid point-of-care blood gas testing system with integrated hemolysis detection—has been honored with four major awards, recognizing its significant contributions to medical technology.
Do you remember the first months in your current Company? Do you remember when you wondered what your line manager and colleagues thought about you as a new team member?
In October 2024 Omixon has become part of Werfen, founded in 2011 in Budapest, Hungary, with about 50 employees, Omixon’s mission is to provide histocompatibility laboratories with innovative technologies to improve transplant outcomes.
As we announced in this article we prepared a booklet about the 2023 EEMEA Scientific Seminars held in Krakow.
EEMEA team loves sharing and strongly believes that helping others makes the world a less difficult place to live in.
We are proud to announce that the GEM Premier 5000 with iQM2 blood gas testing system has reached a significant milestone, with over 15,000 systems installed in hospitals globally,
making it the fastest-growing GEM Premier system in Werfen’s history.
From May 15 to 17 the iconic Werfen Tower in Barcelona hosted the official welcome to the new Transfusion and Transplant distributors, inviting them to become integral members of the ever-growing EEMEA family.
Dear Werfen Partners and colleagues,
We are pleased to announce that Werfen Academy has surpassed 50,000 users worldwide, doubling its user base in less than two years!
Dear Werfen Partners and colleagues,
As per usual appointment here we come with a comprehensive summary of the most recent Werfen Academy milestones.
On Thursday 16th May, we were delighted to come together as one, to kick off the day all together in a common Transfusion & Transplant session on Marketing Tools where we shared the 2024 marketing plans, strategic objectives and calls to action.
During the T&T Partnership Meeting in Barcelona we had the opportunity to meet many new people and we would like to introduce you the speakers who presented during the 3-day event.
Together with our valued distribution partner Disposet, known better in Turkey as GST Medical, we recently participated in the 72nd Congress of the European Society of Cardiovascular and EndoVascular Surgery (ESCVS).
Dear Valued Partner,
As we embark on a new year filled with promise and opportunities, we are thrilled to extend a warm welcome to each and every one of you to the first edition of our quarterly Good Morning EEMEA!
First and foremost, we are excited to remember that our Werfen family has expanded significantly with the recent acquisition of Immucor, announced last year, bringing onboard new colleagues, Partners and opportunities! This is a testament to our continued growth and commitment to delivering innovative solutions in healthcare. We extend a heartfelt welcome to our new colleagues and Partners and look forward to the exciting collaborations and achievements that lie ahead as we unite under the Werfen banner: We are one!
Werfen is committed to help raise awareness on issues that impede appropriate patient care. On March 8th and for International Women’s Day, we raise awareness to #InspireInclusion by inspiring action that help women and girls make informed decisions about their health.
In a world where exceptional customer experiences are not just a goal but a need, we are thrilled to announce a significant evolution in the EEMEA organization: the expansion of our Customer Support team.
The awesome Emporda region in Spain hosted the “We are One” EEMEA 2024 Kick Off Meeting: the team, 53 people from Milan, Dubai, Barcelona and Dreiech gathered in a wonderful seafront location to attend a 3-day event, from 16th to 19th of January, of business reviews, HR updates and Marketing and Customer Support Call to Actions.
Eastern Europe and Baltics Kick-Off 2024 event, which took place in Budapest from January 29th to 31st, was a great success. The event's motto, "We are One” – “Motivated and Healthy Team”, truly encapsulated the spirit of unity that was present throughout the 2-day event.
In a significant achievement, Werfen & AFMS has recently marked a great victory in a coagulation tender for Sulaiman Habib Group, the largest private hospital chain in the Kingdom of Saudi Arabia.
In February, the EEMEA ACDx Team completed a 2-day Launch Training for the new Acute Care Diagnostics solutions at the Werfen Learning Center in Dubai.
In 2024 Werfen EEMEA has launched its first Digital Campaign, as a detailed and phased approach, to enhance its digital presence and strengthen partnerships with customers on HemoHub – Intelligent Data Manager.
The Werfen team has completed a major competitive conversion in North America, at CommonSpirit Health. As the second largest health system in the US, CommonSpirit comprises 142 hospitals across 21 states.
We are pleased to announce that we have recently obtained the CE (Conformité Européenne) mark for the Aptiva® Antiphospholipid Syndrome (APS) Immunoglobulin G (IgG) and Immunoglobulin M (IgM) reagents.
Digital solutions are quite often downgraded to secondary status, not recognized as primary products but rather as ancillary components buried within the overall solution.
Why do some individuals flourish in their professional development? Is it merely a matter of innate talent, or does something more significant play a role?
Two months after the official launch of the EEMEA WhatsApp Channel we are happy to share that our follower base is increasing every day.
For those of you who did not join yet, we would like tto present again some of the main features and benefits of WhatsApp Channels:
Dear Werfen Partner,
If you have clicked and opened this article it means you are eager to read about the latest statistics and updates from Werfen Academy, so we won't let you down!
Dear Werfen Partners and colleagues,
Since its introduction, Werfen Academy has offered a comprehensive library of interactive education, webinars and operator trainings. Our e-learning platform is evolving day after day, allowing users to manage trainings on a single place, assign courses to their teams, and track progresses.
As we embrace the festive spirit that surrounds this time of year, we reflect on the collaborative efforts that have shaped our journey. Your dedication, hard work, and commitment to excellence have been the driving force behind our achievements. Together, we have expanded our presence in all EEMEA geographies, reaching new heights and establishing strong partnerships across these regions.
In a remarkable gathering of experts and professionals as well as influential stakeholders in the medical sector, the city of Krakow (Poland) played host to the EEMEA Scientific Seminars from November 6 to 10.
The 10th International Autoimmunity Seminar, held on November 7th and 8th, 2023, in Krakow, Poland, brought together 170 delegates from 30 countries in the EEMEA region.
The 4th Edition of the EEMEA Acute care Experts Meeting was held on November 7 & 8 in Krakow, Poland with the esteemed presence of more than 120 delegates from 27 countries representing Europe, Middle East, Africa and India.
From November 9 and 10, the 14th Advanced Hemostasis Seminar took place in Krakow with 200+ attendees on-site from countries in East and North Europe, Middle East, Africa, and India.
Werfen has hit a major milestone with more than 1,000 GEM Hemochron 100 whole blood hemostasis systems placed in hospitals around the world.
In an era where digital communication has become imperative for businesses, Werfen, a global leader in in-vitro diagnostics (IVD) and healthcare solutions, has announced its latest venture - a dedicated WhatsApp channel for the EEMEA (Eastern Europe, Middle East, and Africa) region.
The American Association for Clinical Chemistry Scientific Meeting and Clinical Lab Expo 2023 kicked off with the introduction of their new name, the Association for Diagnostics & Laboratory Medicine (ADLM),
Dear Werfen Partners and colleagues,
This year is coming to an end, and here we are to sum up all our 2023 achievements. First of all, a big thanks to all of you for your multiple efforts that allowed us to conquer the 2000 users milestone!
As the year draws to a close, many organizations around the globe engage in the critical step of the Performance Management process, the Year-End Appraisal.
2023 marked a pivotal year for HemoHub, achieving 8x installations in a year, a testament to the company's robust and strategic marketing efforts. This remarkable success can be traced back to 2019 when HemoHub initiated a series of marketing activities that laid the foundation for this growth.
Welcome back from holiday!
We really hope you all had an amazing and relaxing summer break! After recharging our batteries, we are ready to restart our activities and begin new projects. Let’s discover what happened lately and what is waiting for you this fall: the main congress reports (AACC and ISTH), upcoming webinar and training, our 2023 Scientific Seminars in Krakow in November, news and updates in Werfen Academy, good advices from Human Resources to guide teams to success.
Enjoy this issue and have a great restart!
Pepe Zamora, Vice President Commercial Operations EEMEA
The XXXI Congress of the ISTH was held from June 24 to June 28, 2023, in Montreal, Canada. More than 5,250 delegates from 107 countries worldwide, participated in educational seminars, presentation theaters and symposia, poster sessions, and the exhibit hall.
Two months left to welcome you to the 2023 EEMEA Scientific Seminars! The latest updates in Hemostasis, Acute Care Diagnostics and Autoimmunity are ready to be shared and discussed in our most important scientific event.
Werfen wowed at the American Association for Clinical Chemistry (AACC) 2023 Scientific Meeting and Clinical Lab Expo in Anaheim, California, from July 23 to 27. Our large 60x60’ and accompanying 20x20’ booths showcased products and solutions across Hemostasis, Acute Care, Autoimmunity, OEM, and for the first time, Transfusion and Transplant.
Automation in Laboratories is becoming more and more a trend in the market. It doubled the growth in the last 5 years (2018-2023), while for Hemostasis Workcell the growth has been even higher (Source: IQVIA (BBC) and internal data).
The University Clinical Center was established in 2019 as a result of the consolidation of three clinical hospitals of the Medical University of Warsaw. The center includes 3 hospitals: Central Clinical Hospital (the largest hospital in Warsaw, 1100 beds), Infant Jesus Clinical Hospital and Children’s Clinical Hospital.
The last tender was the first tender involving 3 laboratories of these hospitals after consolidation.
Dear Werfen Academy supporters,
We hope you had a nice and relaxing summer break.
Let’s kick off the last part of the year with some exciting statistics on our e-learning platform. As you can see from the chart, we are getting closer to 2000 users… Valentina and I are already planning a surprise for when it happens, so stay tuned!
With regulatory bodies around the world, including CLIA, CAP, the Joint Commission, COLA, ISO, and Accreditation Canada, making significant changes, it can be challenging, yet essential, to keep abreast of requirements for continued laboratory compliance.
Do you remember having started a new job and after a few days wondering if there were any unwritten rules that you should have known to better navigate the workplace, collaborate with your team, and perform successfully?
Dear Werfen Partners,
We usually say: “People First”, and our 9th Partnership Meeting has been a good example of it. We have also seen how the diversity of our ecosystem is “Powering our Future”, not for nothing the powerful motto of this year meeting!
The latest Innovations of Werfen Acute Care Diagnostics (ACDx) arrived also in EEMEA to further integrate and simplify point-of-care testing! The EEMEA ACDx Team is super excited for the Launch of the New ACDx Products: GEM Premier ChemSTAT - the POC Chemistry Analyzer that provides Lab-Quality results for the Basic Metabolic Panel; GEM Hemochron 100 - the newest Activated Clotting Time device on the market; GEMweb Live – the real-time on-screen viewer that consolidates results from Werfen ACDx systems directly into the Cardio Vascular Operating Room (CVOR) and other clinical settings.
The Acute Care Diagnostics (ACD) Breakout Sessions on 24th and 25th May at the 9th EEMEA Partnership Meeting witnessed an inspiring display of collaboration and shared vision as the Distribution Partners from all the three business lines gathered together – Blood Gas, Patient Blood Management and Whole Blood Hemostasis.
AID Breakout session The meeting started on Wednesday afternoon, May 24th, with a breakout session featuring an opening lecture delivered by our partner Ruwag. The purpose of the lecture was to celebrate the successful deployment of the new Aptiva technology at two AID centers located in Switzerland. We then proceeded with a presentation on our achievements in 2022, with a special focus on our recent Autoimmunity Review publication about the 9th Werfen International Autoimmunity seminar. We concluded the meeting with updates on the Integrated Lab and BIO-FLASH.
We’re just back from an exciting week in Rome for our 9th EEMEA Partnership Meeting, so we would like to offer the readers a quick summary about the Customer Support Breakout Session on May 25th. Out of the 240+ attendees joining us in the comfortable meeting rooms of Hotel Villa Pamphili in Rome, close to 50 people registered to participate in our session on Thursday.
External speakers are becoming more and more a tradition as part of our last EEMEA Partnership Meeting editions. For this year event, Werfen brought Luigi Mazzola, a former Executive Performance Coordinator at Ferrari F1 Team.
For Werfen, sustainability is operating our business satisfying the needs of our employees, partners and customers, now and in the future, without compromising the needs of our planet and our future generations, while remaining profitable.
During the Partnership Meeting, we had the chance to reflect together on the importance of cross-collaboration between different departments and teams for driving a high-performing business.
Cross-collaboration is not just about teamworking but refers to the ability of teams to reach their full potential, achieving results that are not just the sum of each team’s efforts, but much more for the benefit of our customers, partners, and the organization itself.
We had the honor of hosting over 250 distributors across EEMEA countries, in addition to the attendance of the plenaries and breakout sessions, we had the opportunity to meet with some of them to discuss how we can adapt our strategy to each market, always creating value and synergies as partners to Power the Future.
Here’s what our partner’s had to say about their attendance to the meeting:
We are delighted to share the exciting news that the article titled "Autoantibodies testing in autoimmunity: Diagnostic, prognostic, and classification value" has been published in the prestigious journal Autoimmunity Review and is now available online.
Dear Partner,
Welcome to the usual appointment with our Werfen Academy Corner!
To date we’ve reached 1532 total users, one fourth of which are from Saudi Arabia, where AFMS has decided to dedicate one Werfen Academy Champion for each business line to better disseminate the usage of our e-learning platform. Romania and Poland are also working very hard, with Poland in particular having translated more than 50 courses in local language, a great advantage for all the customers eager to watch additional trainings and absorb more content easily!
We are thrilled to announce that Werfen and AFMS have won the biggest POCT tender released by NUPCO in 2022. Our joint bid was successful in securing the tender, which will have a significant impact on the healthcare sector in Saudi Arabia.
Overall, the data suggests that women and girls with bleeding disorders face unique challenges in receiving a timely diagnosis and appropriate treatment.
Dear Good Morning EEMEA reader,
Holiday's Season is approaching, and we are proud to deliver an issue of our newsletter with plenty of new articles.
Main focus is on our recent Advanced Seminars and Expert Meeting events, held in Budapest a few weeks ago. Then our usual appointment with Werfen Academy will provide latest updates on our e-Learning Platform.
And much more: our corner dedicated to Human Resources topics, Corporate Social Responsibility and themes regarding Sustainability, Emergency, Bambini Cardiopatici nel Mondo.
A very rich issue, that you'll love to read immediately!
We are pleased to share the fourth video in the Sustainability series. Every few months, our Global Communications team prepares a seed of information with short but insightful tips or tools to get you clued-up on sustainability and our efforts and programs.

